Mirum Pharmaceuticals annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Mirum Pharmaceuticals Depreciation & Amortization Growth & History (MIRM)
Mirum Pharmaceuticals's depreciation and amortization was $24.2M for fiscal 2025.
View full Mirum Pharmaceuticals company overviewMirum Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24.2M | $615,000 | +2.60% |
| 2024 | 2024-12-31 | $23.6M | $12.8M | +118.20% |
| 2023 | 2023-12-31 | $10.8M | $7.6M | +234.43% |
| 2022 | 2022-12-31 | $3.2M | $2.6M | +444.20% |
| 2021 | 2021-12-31 | $595,000 | $290,000 | +95.08% |
| 2020 | 2020-12-31 | $305,000 | $166,000 | +119.42% |
| 2019 | 2019-12-31 | $139,000 | — | — |
Mirum Pharmaceuticals quarterly depreciation and amortization
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.9M | $880,000 | +14.53% |
| Q1 2026 | 2026-03-31 | $6.9M | $822,000 | +13.58% |
| Q4 2025 | 2025-12-31 | $6.1M | — | — |
| Q3 2025 | 2025-09-30 | $6.1M | $7,000 | +0.12% |
| Q2 2025 | 2025-06-30 | $6.1M | $202,000 | +3.45% |
| Q1 2025 | 2025-03-31 | $6.1M | $388,000 | +6.85% |
| Q3 2024 | 2024-09-30 | $6.1M | $3.4M | +127.46% |
| Q2 2024 | 2024-06-30 | $5.9M | $4.5M | +338.17% |
| Q1 2024 | 2024-03-31 | $5.7M | $4.3M | +323.64% |
| Q3 2023 | 2023-09-30 | $2.7M | $1.6M | +142.88% |
| Q2 2023 | 2023-06-30 | $1.3M | $737,000 | +123.04% |
| Q1 2023 | 2023-03-31 | $1.3M | $995,000 | +290.94% |
| Q3 2022 | 2022-09-30 | $1.1M | $1.0M | +1204.76% |
| Q2 2022 | 2022-06-30 | $599,000 | $520,000 | +658.23% |
| Q1 2022 | 2022-03-31 | $342,000 | $252,000 | +280.00% |
| Q3 2021 | 2021-09-30 | $84,000 | $7,000 | +9.09% |
| Q2 2021 | 2021-06-30 | $79,000 | $9,000 | +12.86% |
| Q1 2021 | 2021-03-31 | $90,000 | $17,000 | +23.29% |
| Q3 2020 | 2020-09-30 | $77,000 | $40,000 | +108.11% |
| Q2 2020 | 2020-06-30 | $70,000 | $27,000 | +62.79% |
| Q1 2020 | 2020-03-31 | $73,000 | $73,000 | — |
| Q3 2019 | 2019-09-30 | $37,000 | — | — |
| Q2 2019 | 2019-06-30 | $43,000 | — | — |
| Q1 2019 | 2019-03-31 | $0 | — | — |
Mirum Pharmaceuticals depreciation and amortization trends
Over the last five fiscal years, Mirum Pharmaceuticals's depreciation and amortization increased from $305,000 to $24.2M, a change of $23.9M. The latest reported quarter, Q2 2026, shows $6.9M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mirum Pharmaceuticals source filings ↗